- Needham cut the price target for Wix.com Ltd. WIX from $125 to $120. Needham analyst Bernie McTernan maintained a Buy rating. Wix.com shares dropped 3.2% to close at $78.09 on Friday.
- Telsey Advisory Group slashed the price target for The Children's Place, Inc. PLCE from $44 to $30. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. Children's Place shares rose 1% to $23.32 in pre-market trading.
- B of A Securities cut the price target for Foot Locker, Inc. FL from $45 to $36. B of A Securities analyst Lorraine Hutchinson maintained a Neutral rating. Foot Locker shares fell 2.1% to $29.59 in pre-market trading.
- Citigroup raised Norfolk Southern Corporation NSC price target from $226 to $257. Citigroup analyst Christian Wetherbee upgraded the stock from Neutral to Buy. Norfolk Southern shares rose 0.7% to close at $217.74 on Friday.
- UBS boosted DraftKings Inc. DKNG price target from $19 to $30. UBS analyst Robin Farley upgraded the stock from Neutral to Buy. DraftKings shares rose 0.5% to close at $24.11 on Friday.
- Barclays boosted SentinelOne, Inc. S price target from $17 to $22. Barclays analyst Saket Kalia maintained an Equal-Weight rating. SentinelOne shares fell 1.1% to $18.55 in pre-market trading.
- Williams Trading cut the price target for NIKE, Inc. NKE from $120 to $95. Williams Trading analyst Sam Poser downgraded the stock from Hold to Sell. NIKE shares fell 1.1% to $113.50 in pre-market trading.
- William Blair cut Hibbett, Inc. HIBB price target from $82 to $54. William Blair analyst Sam Poser downgraded the stock from Buy to Hold. Hibbett shares fell 0.6% to $47.26 in pre-market trading.
- Keybanc increased NVIDIA Corporation NVDA price target from $320 to $375. Keybanc analyst John Vinh maintained an Overweight rating. NVIDIA shares fell 1.3% to $308.50 in pre-market trading.
- Barclays increased Walmart Inc. WMT price target from $159 to $162. Barclays analyst Seth Sigman maintained an Overweight rating. Walmart shares rose 0.7% to $150.89 in pre-market trading.
- HC Wainwright & Co. boosted Krystal Biotech, Inc. KRYS price target from $119 to $139. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. Krystal Biotech shares rose 9.9% to close at $96.06 on Friday.
Check This Out: S&P 500 Records Best Weekly Performance Since March; Market Volatility Increases
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in